Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206138982> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4206138982 endingPage "51" @default.
- W4206138982 startingPage "IA" @default.
- W4206138982 abstract "Abstract The low representation of underrepresented minorities in clinical trials is well known. Unfortunately, there appears to be modest progress in the inclusion of these groups in the nearly 30 years since the NIH Revitalization Act of 1993. Racial and ethnic diversity in clinical trials is imperative for ensuring that novel cancer therapies, behavioral interventions and other types of scientific advances reach and are relevant to all population segments. It will be impossible to eliminate disparities and achieve health equity without diversity and inclusion in clinical research. Many barriers exist to clinical trials and some may be exacerbated among racial/ethnic minorities. This presentation will discuss multilevel barriers to participation in clinical research, share engagement principles related to partnerships with African American/Black and Latino/Latinx populations, and provide lessons learned from institutional and investigator led-initiatives. Data sources include chart reviews, patient interviews and surveys. Selected clinical studies will be discussed along with qualitative and quantitative data. The overall goal is to identify actionable steps towards a collective path of improving minority participation in clinical trials. Strategies that optimize opportunities for system change may have greater impact than strategies that focus solely on patient and/or community attitudes or behaviors. Given the COVID-19 pandemic, public awareness about clinical trials may be at a record high. Thus, community conversations about science and the clarion call for social justice may be the energy needed for cancer scientists to collaborate and change the narrative regarding participation of underrepresented minorities in research. Citation Format: Vanessa B. Sheppard. If not now, then when? Tackling barriers to clinical trials to ensure inclusion of underrepresented minorities [abstract]. In: Proceedings of the AACR Virtual Conference: 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2021 Oct 6-8. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr IA-51." @default.
- W4206138982 created "2022-01-26" @default.
- W4206138982 creator A5042631076 @default.
- W4206138982 date "2022-01-01" @default.
- W4206138982 modified "2023-10-07" @default.
- W4206138982 title "Abstract IA-51: If not now, then when? Tackling barriers to clinical trials to ensure inclusion of underrepresented minorities" @default.
- W4206138982 doi "https://doi.org/10.1158/1538-7755.disp21-ia-51" @default.
- W4206138982 hasPublicationYear "2022" @default.
- W4206138982 type Work @default.
- W4206138982 citedByCount "0" @default.
- W4206138982 crossrefType "journal-article" @default.
- W4206138982 hasAuthorship W4206138982A5042631076 @default.
- W4206138982 hasConcept C109359841 @default.
- W4206138982 hasConcept C137403100 @default.
- W4206138982 hasConcept C138816342 @default.
- W4206138982 hasConcept C142724271 @default.
- W4206138982 hasConcept C15744967 @default.
- W4206138982 hasConcept C159110408 @default.
- W4206138982 hasConcept C17744445 @default.
- W4206138982 hasConcept C199539241 @default.
- W4206138982 hasConcept C2250968 @default.
- W4206138982 hasConcept C27415008 @default.
- W4206138982 hasConcept C2781316041 @default.
- W4206138982 hasConcept C2908647359 @default.
- W4206138982 hasConcept C2910734998 @default.
- W4206138982 hasConcept C39549134 @default.
- W4206138982 hasConcept C509550671 @default.
- W4206138982 hasConcept C535046627 @default.
- W4206138982 hasConcept C71924100 @default.
- W4206138982 hasConcept C74909509 @default.
- W4206138982 hasConcept C77805123 @default.
- W4206138982 hasConcept C99454951 @default.
- W4206138982 hasConceptScore W4206138982C109359841 @default.
- W4206138982 hasConceptScore W4206138982C137403100 @default.
- W4206138982 hasConceptScore W4206138982C138816342 @default.
- W4206138982 hasConceptScore W4206138982C142724271 @default.
- W4206138982 hasConceptScore W4206138982C15744967 @default.
- W4206138982 hasConceptScore W4206138982C159110408 @default.
- W4206138982 hasConceptScore W4206138982C17744445 @default.
- W4206138982 hasConceptScore W4206138982C199539241 @default.
- W4206138982 hasConceptScore W4206138982C2250968 @default.
- W4206138982 hasConceptScore W4206138982C27415008 @default.
- W4206138982 hasConceptScore W4206138982C2781316041 @default.
- W4206138982 hasConceptScore W4206138982C2908647359 @default.
- W4206138982 hasConceptScore W4206138982C2910734998 @default.
- W4206138982 hasConceptScore W4206138982C39549134 @default.
- W4206138982 hasConceptScore W4206138982C509550671 @default.
- W4206138982 hasConceptScore W4206138982C535046627 @default.
- W4206138982 hasConceptScore W4206138982C71924100 @default.
- W4206138982 hasConceptScore W4206138982C74909509 @default.
- W4206138982 hasConceptScore W4206138982C77805123 @default.
- W4206138982 hasConceptScore W4206138982C99454951 @default.
- W4206138982 hasIssue "1_Supplement" @default.
- W4206138982 hasLocation W42061389821 @default.
- W4206138982 hasOpenAccess W4206138982 @default.
- W4206138982 hasPrimaryLocation W42061389821 @default.
- W4206138982 hasRelatedWork W1522055934 @default.
- W4206138982 hasRelatedWork W2189264121 @default.
- W4206138982 hasRelatedWork W2997729144 @default.
- W4206138982 hasRelatedWork W3045822873 @default.
- W4206138982 hasRelatedWork W3185163327 @default.
- W4206138982 hasRelatedWork W4285301380 @default.
- W4206138982 hasRelatedWork W4308077397 @default.
- W4206138982 hasRelatedWork W4327943386 @default.
- W4206138982 hasRelatedWork W4386230808 @default.
- W4206138982 hasRelatedWork W4387268988 @default.
- W4206138982 hasVolume "31" @default.
- W4206138982 isParatext "false" @default.
- W4206138982 isRetracted "false" @default.
- W4206138982 workType "article" @default.